Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells.
Cancer cell therapy is evolving toward off-the-shelf treatments that could reach patients beyond major academic medical centers.
This comprehensive review in Signal Transduction and Targeted Therapy surveys the rapidly evolving landscape of cancer cell therapy, from established autologous CAR-T constructs to stem cell-derived immune effectors and combination approaches. The review synthesizes key clinical data and highlights the transition toward scalable allogeneic platforms that could democratize cell therapy access beyond major academic centers.
What the study was
- Study design
- Review
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Signal Transduct Target Ther
Why it surfaced
Signal Transduction and Targeted Therapy is a highly cited Nature Publishing Group journal; comprehensive cell therapy survey is directly relevant to immunotherapy watchlist; timely coverage of allogeneic platforms.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.